liquid

DRUG3 trials

Sponsors

Centre Hospitalier Regional Et Universitaire De Brest, GH Research Ireland Limited, The Miriam Hospital

Conditions

Dental careMicrobicide Delivery System Perceptibility and AcceptabilityTreatment-resistant depression (TRD)

Phase 2

A randomized, double-blind, placebo-controlled, Phase 2b trial with an open-label extension to determine the safety and efficacy of GH001 in patients with treatment-resistant depression.

CompletedCTIS2023-510047-37-00

GH Research Ireland LimitedTreatment-resistant depression (TRD)

Start: 2023-03-30End: 2025-03-11Target: 81Updated: 2024-11-08

Phase 3

Prospective double-blind randomized comparative study of the use of methoxyflurane vs placebo in the management of pain in oral and dental emergencies in adults: METODO (METhoxyflurane in ODOntology)

CompletedCTIS2023-508216-29-00

Centre Hospitalier Regional Et Universitaire De BrestDental care

Start: 2024-10-14End: 2025-10-03Target: 192Updated: 2024-03-18

Unknown Phase

Developing Rectal USPE Measures

CompletedNCT02102867

The Miriam HospitalMicrobicide Delivery System Perceptibility and Acceptability

Start: 2014-04-01End: 2022-04-01Updated: 2026-02-05